Press Releases

AnteoTech Secures CE Certification for Its Versatile EuGeni™ Rapid Diagnostic Platform

AnteoTech has announced that its EuGeni™ Reader and accompanying COVID-19 Antigen Rapid Test (ART) have received Conformité Européene (CE) Mark registration as the company looks to swiftly progress with European distribution.

Medics.Academy and Guy's and St Thomas' NHS Foundation Trust combine forces to equip healthcare workers for the genomic revolution

Medics.Academy, a UK company delivering global access to world-leading medical education, has collaborated with Guy's and St Thomas' NHS Foundation Trust, national leaders in the identification, diagnosis and management of the care of several genetic conditions, to launch Nucleus.

BioIVT Will Highlight Novel Hepatotoxicity Models at the 2021 SOT Annual Meeting and ToxExpo

Presentations will focus on long-term, lipid-loading models and the role of impaired hepatic transporter function in drug-induced liver injury.

Thermo Fisher Scientific Launches Customizable TaqMan SARS-CoV-2 Mutation Panel

Proscia and Ibex Medical Analytics Partner to Improve Prostate Cancer Diagnosis with AI-powered Workflows

CRISPR/Cas9 Gene Editing Service Now Available by the GutFlora Omics Platform

Complete Family of Next Generation Centrifuges Deliver Optimal Sample Safety, Functionality and Ergonomics

Thermo Fisher Scientific announced today the launch of new 1.6 L benchtop and 4 L floor-standing systems, the latest additions to the Thermo Scientific General Purpose Pro Centrifuge Series, designed to deliver enhanced sample safety and reproducibility, improved ergonomics and reduced noise levels.

Aptamer Group and Mologic enter commercial partnership to develop aptamer-based SARS-CoV-2 rapid antigen test

Aptamer Group and Mologic are working towards CE marking of Aptamer Group’s AptaDx SARS-CoV-2 lateral flow rapid antigen test for professional use, to detect the SARS-CoV-2 spike protein antigen in anterior nasal swabs. Initial laboratory tests have demonstrated excellent sensitivity, being able to detect as little as 1000 virus particles per mL, and further clinical validation to support the CE marking will be performed at the Integrated COVID Hub North East in Newcastle, UK. As it’s based on aptamers (synthetic nucleic acid-based affinity reagents) rather than standard protein-based affinity reagents, the test would offer significant cost advantages, allowing large scale development and delivery of tests globally, including to low- and middle-income countries.

MicrobioSeq Releases Microecology and Cancer Solutions to Accelerate Your Cancer Research and Discovery

Bioinformatics-Analysis Division Revised Website for Better User Experience

Irish Company Develops Cloud-Based App Aimed to Accelerate Global COVID-19 Vaccination Process

BOC Sciences Provides Extensive Catalog of Building Blocks

MICROSENSDX RapiPRO™ LAMP for SARS-CoV-2 RECEIVES CE MARK APPROVAL

MedAI Integrates Its Drug Research and Development Platform for the Pharmaceutical Industry

Thermo Fisher Scientific Collaborates with Artificial to Enhance COVID-19 Diagnostic Testing Solution

Thermo Fisher Scientific, which today announced their collaboration with Artificial to increase the productivity of COVID-19 testing through an integrated and comprehensive software automation platform.

Ceryx Medical appoints Chas Taylor as Chairman

Ceryx Medical, the business behind a revolutionary technology that could significantly change the way patients with serious heart problems are treated, has appointed Chas Taylor, a leading medical devices entrepreneur, as Chairman.

Creative BioMart Biomarker Released Multiple Biomarker Detection Service

Lifeasible Updated Its Animal Metabolomics Analysis Service

Continuous manufacturing μLOT® enabling technology could cut pharma industry’s use of toxic chemicals by one hundred times

Speaking at the ‘Innovative Chemistry for Peptide Manufacturing and Analysis’ conference, SB3000’s Chief R&D Officer Jens Bukrinski revealed that continuous manufacturing μLOT® technology could reduce the pharmaceutical industry’s use of toxic chemicals by 100 times.

Formulationbio Newly Launches Disintegrant Excipients for Pharmaceutical Preparation